Medicinal Chemistry
A section of Molecules (ISSN 1420-3049).
Section Information
The Medicinal Chemistry Section of the journal Molecules publishes original research and review articles that increase our understanding of how the chemical structure of bioactive molecules determines their pharmacodynamic, pharmacokinetic, and physicochemical properties and, hence, their therapeutic potential. In particular, this Section mainly invites contributions that report on:
-The design, synthesis, chemical characterization1, and biological evaluation of novel compounds against biological targets of therapeutic, diagnostic, or theranostic interest, and/or the assessment of their physicochemical and pharmacokinetic properties;
-The isolation from herbal plants and separate biological characterization of individual bioactive compounds and/or their semisynthetic derivatives;
-Hit-to-lead projects that lead to a significant optimization of potency, or physicochemical and/or pharmacokinetic properties;
-Computational2, molecular biology, and/or structural biology studies that shed light on the structure and function of biological targets of therapeutic, diagnostic, or theranostic interest and on their interaction with known or novel compounds, thereby enabling the rational design of optimized ligands;
-Computational2 and biological studies of known drugs or their derivatives that address their interaction with novel biological targets for repositioning purposes;
-Novel synthetic, computational2, or biological methodologies of relevance in medicinal chemistry;
-Development and application of materials for medicinal chemistry purposes, such as drug delivery and drug targeting.
Manuscripts that report on the biological evaluation of mixtures of compounds, such as plant extracts, or purely pharmacological studies that look deeper into the standard action of well-established drugs will normally not be considered for publication in this Section.
1 Authors are encouraged to present additional data and files about the purity and characterization of new compounds that are auxiliary to the main content of the article. The goal is to keep the main body of the article concise but also provide detailed information that increases reproducibility and availability of presented research. Examples include (but are not limited to) NMR spectra, or routine preparations of substrates. All new entities must be fully characterized by appropriate analytical methods with sufficient evidence for composition, structure, and purity. The identity and bulk purity of compounds and materials should be verified with elemental analysis or other appropriate methods.
2 Manuscripts that mainly describe computational studies need to be accompanied by experimental validation. For QSAR modeling, a sufficient number of new compounds should be included and discussed. As with chemical and biological methods, authors should present sufficient information to allow computational methods to be reproduced and tested in other laboratories.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- 3D Printing Technique for the Manufacturing of Drug Delivery Systems (Deadline: 30 September 2023)
- The Development and Applications of Aptamers (Deadline: 30 September 2023)
- Synthesis and Evaluation of Biologically Active Compounds from Heterocycles Class (Deadline: 30 September 2023)
- Chemopreventive and Antioxidant Activity of Plant Extracts and Other Phytochemical Compounds (Deadline: 30 September 2023)
- Innovative Technologies for the Sustainable Development of Next-Generation Plant-Based Drugs (Deadline: 30 September 2023)
- Innovative Drug Discovery and Mechanism Studies Based on Phenotypic Screening (Deadline: 30 September 2023)
- Macromolecular Nanotechnology in Medicine—Latest Research and Approaches (Deadline: 30 September 2023)
- Essential Oils: Antimicrobial Activities and Food Applications (Deadline: 30 September 2023)
- Recent Advances in Anticancer Drugs III (Deadline: 30 September 2023)
- Natural Compounds for Disease and Health (Deadline: 30 September 2023)
- New Potential Antimicrobial Agents: Design, Synthesis and Biological Evaluation (Deadline: 30 September 2023)
- Novel Scaffold: From Synthesis to Therapeutic Applications (Deadline: 30 September 2023)
- Neuroprotective Agents II (Deadline: 30 September 2023)
- Perspectives in Nanotechnology Based Innovative Applications in Diagnosis and Treatment of Infectious and Non-infectious Disease (Deadline: 30 September 2023)
- Antimetastatic Molecules: Perspective towards Treatment of Solid Cancers (Deadline: 30 September 2023)
- Antibacterial Adjuvants Screening from Plants and Molecular Mechanism Investigation (Deadline: 30 September 2023)
- Recent Advances in the Research of Natural Products: Isolation, Identification, Physicochemical Properties and Bioactivities (Deadline: 30 September 2023)
- Discovery and Development of Neuroprotective Agents (Deadline: 30 September 2023)
- Bioelements and Bioactive Metabolites of Natural Origin—Health-Promoting Applications (Deadline: 30 September 2023)
- Molecular Imaging in Drug Research (Deadline: 30 September 2023)
- Coordination Compounds in Medicinal Chemistry: Past, Present and Perspectives (Deadline: 30 September 2023)
- Research on Discovery, Bioactivity, and Mechanism of Natural Cyclopeptides (Deadline: 30 September 2023)
- Bioactive Molecules as Multidrug Resistance Modulator (Deadline: 30 September 2023)
- Stilbene Scaffold: From Nature to Synthetic Derivatives (Deadline: 30 September 2023)
- Cannabinergic Ligands: Chemistry, Pharmacology and Therapeutic Potential (Deadline: 30 September 2023)
- Multitargeting Agents for Alzheimer's Disease (Deadline: 30 September 2023)
- Nitric Oxide Modulators in Health and Disease II (Deadline: 30 September 2023)
- Biologically Active Plant-Derived Pharmaceuticals: Recent Advances and Future Prospects (Deadline: 30 September 2023)
- Inorganic Nanoparticles in Biomedical Applications (Deadline: 30 September 2023)
- New Strategies and Drugs Against Intracellular Pathogens (Deadline: 30 September 2023)
- Discovery of Enzyme Inhibitors from Natural Products II (Deadline: 30 September 2023)
- Novel Aspects of Molecular Targets for Antidepressant Drugs (Deadline: 30 September 2023)
- Synthesis and Evaluation of Biologically Active Compounds from Five Membered Heterocycles (Deadline: 30 September 2023)
- Bioactive Small Molecules: Design, Synthesis, and Applications (Deadline: 1 October 2023)
- Radiopharmaceuticals (Deadline: 10 October 2023)
- Chemistry, Biology and Pharmacology of Modulators of Oxidative Stress (Deadline: 15 October 2023)
- Oxidative Stress as a Pharmacological Target for Medicinal Chemistry II (Deadline: 15 October 2023)
- Recent Studies on Anticancer Agents from Natural Products (Deadline: 15 October 2023)
- Progress in Drug Development for Inflammatory Diseases (Deadline: 20 October 2023)
- Discovering New Drug Targets for Neurodegenerative Disorders (Deadline: 30 October 2023)
- Multitarget Ligands in Drug Discovery (Deadline: 31 October 2023)
- Bioactive Compounds from Natural Materials: A New Perspective in Medicinal Chemistry (Deadline: 31 October 2023)
- Lead Compounds Discovery and Antitumor Drug Design (Deadline: 31 October 2023)
- Synthesis, Characterization and Biological Activity of Pharmaceutically Important Drug Molecules (Deadline: 31 October 2023)
- Design, Synthesis, and Evaluation of Anticancer Drugs (Deadline: 31 October 2023)
- Medicinal Chemistry in China II (Deadline: 31 October 2023)
- Recent Advances in the Discovery of Biologically Relevant Small Molecules (Deadline: 31 October 2023)
- Natural Medicines: Chemical Constituents and Pharmacological Activities (Deadline: 31 October 2023)
- The Development of Peptides and Peptide-Modified Delivery Systems (Deadline: 31 October 2023)
- Recent Progress of Structure- and Ligand-Based Kinase Inhibitors Design and Discovery (Deadline: 31 October 2023)
- The Versatility of Curcumin for the Design of Bioactive Compounds (Deadline: 31 October 2023)
- Cutting-Edge Studies of Computational Approaches in Drug Discovery (Deadline: 31 October 2023)
- Synthesis of Heterocyclic Compounds via Cycloadditions: Applications in Medicinal Chemistry (Deadline: 31 October 2023)
- Pharmaceutical Nanotechnology: Drug Delivery Challenges (Deadline: 31 October 2023)
- Novel Therapeutic Targets and Potential Drugs for Inflammatory Disease (Deadline: 31 October 2023)
- Design, Syntheses, and Applications of New Anti-Cancer Inhibitors in Breast and Ovarian Cancer (Deadline: 31 October 2023)
- Innovative Computational and Experimental Approaches for Tackling Neurodegenerative Diseases (Deadline: 31 October 2023)
- New Therapeutic Targets for Cancer (Deadline: 31 October 2023)
- New Advances in Radiopharmaceutical Sciences (Deadline: 31 October 2023)
- Recent Progress in Cancer Therapy (Deadline: 31 October 2023)
- Design, Synthesis and Structure-Activity Relationship of Biologically Active Inhibitors (Deadline: 31 October 2023)
- Small-Molecule Inhibitors of Tubulin Polymerization: Recent Advances (Deadline: 31 October 2023)
- Nanoparticles: A Salvage to Overcome Drug Resistant Cancer and Infectious Diseases (Deadline: 31 October 2023)
- Synthesis and Biologically Relevant Heterocyclic Compounds (Deadline: 31 October 2023)
- Advances in Medicinal Chemistry of Antithrombotic Agents (Deadline: 31 October 2023)
- Bioactive Compounds from Natural Sources: Discovery, Evaluation and Applications (Deadline: 31 October 2023)
- Targeted Radionuclide Diagnosis and Therapy of Prostate Cancer—From Basic Research to Clinical Perspectives (Deadline: 31 October 2023)
- Small Molecule Hybrids for Anticancer and Antiviral Therapy (Deadline: 31 October 2023)
- Nano-Based Drug Delivery and Diagnostics: Innovation and Applications (Deadline: 31 October 2023)
- Design, Synthesis and Evaluation of Theranostic Radiopharmaceuticals (Deadline: 31 October 2023)
- Natural Products and Microbiology in Human Health (Deadline: 31 October 2023)
- Nanotechnology and Novel Drug Delivery Systems (Deadline: 31 October 2023)
- Metalloenzyme Inhibitors and Activators III (Deadline: 31 October 2023)
- Discovery of New Anti-cancer Molecules: From Hit Identification to Structure-Activity Relationship Study (Deadline: 31 October 2023)
- The Current Landscape of Nucleic-Acid-Based Drugs (Deadline: 1 November 2023)
- Biocatalysis and Enzymes in Pharmaceutical and Biotechnological Processes (Deadline: 15 November 2023)
- Synthesis and Application of Anticancer Inhibitors (Deadline: 30 November 2023)
- Natural Product in Drug Discovery: Chem-Bioinformatic and Bioactive Compounds Identification (Deadline: 30 November 2023)
- Synthesis, Biotransformation and Neuronal Effects of Heterocyclic Compounds (Deadline: 30 November 2023)
- Computational Chemistry of Pharmaceutical and Biomolecules (Deadline: 30 November 2023)
- Anticancer Research: Towards an Understanding of Cancer and Discovery of New Therapeutic Agents (Deadline: 30 November 2023)
- Design, Synthesis and Biological Evaluation of Medicinal Potential Compounds (Deadline: 30 November 2023)
- Advancement in Design and Synthesis of Novel Drugs (Deadline: 30 November 2023)
- Computational Method in Drug Design and Food Chemistry II (Deadline: 30 November 2023)
- Novel Biologically Active Molecules, Biomaterials and Nanoparticles for the Microbial Biofilm Control in Human Medicine II (Deadline: 30 November 2023)
- Natural Product Chemistry in Drug Discovery (Deadline: 30 November 2023)
- Metal Nanoparticles for a New Generation of Antibacterial Agents (Deadline: 30 November 2023)
- Fluorescent Probe: Design, Synthesis and Application (Deadline: 30 November 2023)
- Neuropeptides: From Physiology to Therapeutic Applications (Deadline: 30 November 2023)
- Recent Advances in Small-Molecule Therapeutics Targeting Signaling Pathways (Deadline: 30 November 2023)
- In-Silico Methods for Drug Design and Discovery (Deadline: 30 November 2023)
- Advances of Polymer Nanocomposites for Antimicrobial Applications (Deadline: 30 November 2023)
- Synthesis, Structure and Evaluation of Anticancer Heterocycles and Related Organometallic Derivatives (Deadline: 30 November 2023)
- Nanoparticles in Cellular Drug Delivery (Deadline: 30 November 2023)
- Anti-Obesity Drug Discovery: Recent Advances and Future Perspectives (Deadline: 30 November 2023)
- Spirocycles in Medicinal Chemistry (Deadline: 30 November 2023)
- Photosensitized Agents for Phototherapy (Deadline: 30 November 2023)
- Therapeutic Agents for Neurodegenerative Disorders (Deadline: 30 November 2023)
- Advances of Enzyme Inhibitors and Activators in Drug Research (Deadline: 30 November 2023)
- Strategies of Molecular Targeting in Malaria Research with Chemical Compounds or Agents (Deadline: 30 November 2023)
- Novel Nanomedicines for Cancer Therapy (Deadline: 30 November 2023)
- Small Molecules as Targeted Anticancer Agents (Deadline: 30 November 2023)
- Applications of Melatonin in Health and Medicinal Chemistry (Deadline: 30 November 2023)
- Design, Synthesis, and Biological Evaluation of Antimicrobial Agents (Deadline: 30 November 2023)
- Targeted Nanomedicine Design (Deadline: 30 November 2023)
- Ligands and Conformational Changes in Receptors (Deadline: 30 November 2023)
- Novel Chemical and Biological Agents in Substance Use Disorder Research (Deadline: 30 November 2023)
- Synthesis, Biological Evaluation and Molecular Modeling of Bioactive Compounds (Deadline: 30 November 2023)
- Advances in Research of Short Peptides II (Deadline: 1 December 2023)
- Naturally Inspired Molecules as Inhibitors in Drug Discovery (Deadline: 15 December 2023)
- Indoles as Promising Scaffold for Drug Discovery: Synthesis, Bioactivities and Applications (Deadline: 22 December 2023)
- Medicinal Plants and Industrial Crops: Phytochemistry and Metabolic Diseases II (Deadline: 30 December 2023)
- Second Edition of Medicinal Chemistry in Asia (Deadline: 30 December 2023)
- Protein Design and Protein Engineering (Deadline: 31 December 2023)
- Novel Insights toward the Development of New Drugs (Deadline: 31 December 2023)
- Biomaterials in Bone Regeneration (Deadline: 31 December 2023)
- Addressing Neurodegenerative Disorders with Monoamine Oxidase and Cholinesterase Inhibitors (Deadline: 31 December 2023)
- Novel Insights in Some Nanotechnological Formulations and Biomedical Applications (Deadline: 31 December 2023)
- Design and Synthesis of Novel Anti-Inflammatory Agents (Deadline: 31 December 2023)
- Fluorescence Probes as Disease Molecular Diagnosis (Deadline: 31 December 2023)
- Dietary Biofactors: Chemistry, Biological Activities, and Roles in Human Health and Disease (Deadline: 31 December 2023)
- Marine Natural Products: A Hidden Wealth and a New Epoch for Drug Development (Deadline: 31 December 2023)
- The Chemical Immobilization and Inactivation of SARS-CoV-2 (Deadline: 31 December 2023)
- Synthesis and Evaluation of Bioactivity of Enzyme Inhibitors (Deadline: 31 December 2023)
- Design, Synthesis and Biological Activity of Novel Antitumor Drugs (Deadline: 31 December 2023)
- Bioactive Compounds in Food: Analysis and Human Health (Deadline: 31 December 2023)
- Drug Candidates for Inflammatory Diseases (Deadline: 31 December 2023)
- Protein Kinase Inhibitors: Design, Specificity and Mechanism of Action (Deadline: 31 December 2023)
- Dopamine Receptors and Neurodegeneration (Deadline: 31 December 2023)
- Heterocycles in Medicinal Chemistry II (Deadline: 31 December 2023)
- Editorial Board Members’ Collection Series: Multitarget-Directed Ligands for the Treatment of Multifactorial Diseases (Deadline: 31 December 2023)
- Heterocyclic Compounds in Drug Discovery and Their Medical Applications (Deadline: 31 December 2023)
- The Design, Synthesis, and Biological Activity of New Drug Candidates (Deadline: 31 December 2023)
- Design, Synthesis and Evaluation of Small Molecule Drugs (Deadline: 31 December 2023)
- 150th Anniversary of the Creation of the Faculty of Pharmacy of Nancy, Université de Lorraine, France (Deadline: 31 December 2023)
- Design and Synthesis of Novel Drugs for the Treatment of Cancer (Deadline: 31 December 2023)
- New Therapeutic Tools against MDR Tumors: Discovery, Synthesis and Evaluation of Bioactive Compounds (Deadline: 31 December 2023)
- NAD Metabolism and Related Drug Compounds (Deadline: 31 December 2023)
- Metabolites from Algae: Discovery, Identification and Bioactive Evaluation (Deadline: 31 December 2023)
- Natural Compounds: A Lead for Drug Discovery and Development (Deadline: 31 December 2023)
- Novel Antibacterial Agents: Discovery, Design, Synthesis, and Evaluation (Deadline: 31 December 2023)
- Tumor-Resident Microbes and Small Molecular Anti-Cancer Drugs in Tumor Microeniroment (Deadline: 31 December 2023)
- Drug Research in Metabolic Bone Diseases and Osteoporosis (Deadline: 31 December 2023)
- New Insights into Biomolecular Structures and Interactions (Deadline: 31 December 2023)
- Plant-Derived Phenolic Compounds: From Molecular Mechanisms to Clinical Application II (Deadline: 31 December 2023)
- Chemistry of Antiparasitic Drugs (Deadline: 31 December 2023)
- Recent Advances in Lysozyme (Deadline: 31 December 2023)
- Molecules4Life—First International Meeting (Deadline: 31 December 2023)
- New Strategies and Approaches in Polypharmacology (Deadline: 31 December 2023)
- Advances in Antibacterial Molecules (Deadline: 31 December 2023)
- Multifunctional Nanomaterials for Bioapplications (Deadline: 31 December 2023)
- Novel Antinociceptive Agents against Persistent Pain (Deadline: 31 December 2023)
- Novel Targeted Radiopharmaceuticals for Diagnosis and Therapy (Deadline: 31 December 2023)
- Small Molecules in Antimicrobial and Anti-quorum Sensing Drug Discovery: Experimental and Computational Approaches (Deadline: 1 January 2024)
- Organic Synthesis and Medicinal Chemistry, Two Inseparable Partners: Recent Advances in Heterocyclic Chemistry (Deadline: 31 January 2024)
- Developing Drug Strategies for the Neuroprotective Treatment (Deadline: 31 January 2024)
- Recent Advances in Fluorescent Probes and Theranostics (Deadline: 31 January 2024)
- Antiproliferative Activities of Natural and Synthetic Compounds (Deadline: 31 January 2024)
- Natural Products: Isolation, Analysis and Biological Activity (Deadline: 31 January 2024)
- Bioactive Compounds for Brain Ischemia and Neurodegenerative Disease—Second Edition (Deadline: 31 January 2024)
- Anti-inflammatory Molecules (Deadline: 31 January 2024)
- Synthesis and Application of Opioids (Deadline: 31 January 2024)
- Medicinal Chemistry Studies of Neglected Diseases (Deadline: 31 January 2024)
- Small Molecules and Peptides: New Advancing Trends in Molecular Targets and Drug Discovery (Deadline: 31 January 2024)
- Phosphates and Their Analogues in Drug Discovery (Deadline: 31 January 2024)
- Recent Advances in Cardiovascular Drug Discovery and Development (Deadline: 31 January 2024)
- Design, Synthesis and Biological Evaluation of Novel Small Molecules Inhibitors (Deadline: 31 January 2024)
- Discovery of Small Molecules for Cancer Therapy: Current Challenges, Recent Trends, and Future Perspectives (Deadline: 31 January 2024)
- Discovery and Development of Targeted Anticancer Nanomedicines (Deadline: 31 January 2024)
- Biofunctional Molecule Exploratory Research on Application in Food and Health II (Deadline: 31 January 2024)
- Multifunctional Conjugated Photosensitizers: Synthesis and Applications in Photodynamic and Phototherapy of Cancers (Deadline: 31 January 2024)
- Design and Drug Screening of Targeted Proteins Inhibitor (Deadline: 31 January 2024)
- Recent Advances in Development of Small Molecules to Fight Cancer (Deadline: 31 January 2024)
- Hybrid and Chimieric Heterocyclic Compounds as Anticancer and Antimicrobial Agents (Deadline: 15 February 2024)
- Opioids and Their Receptors (Deadline: 28 February 2024)
- Cancer Metabolism as a Target for New Oncological Drugs (Deadline: 29 February 2024)
- Breakthroughs and Challenges in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes (Deadline: 29 February 2024)
- Current Advances in the Discovery and Development of New Therapies against Cancer (Deadline: 29 February 2024)
- Polyamine Drug Discovery (Deadline: 29 February 2024)
- Heterocyclic Bioactive Small Molecules: Advances in Structure Analysis and Drug Discovery in Heterocyclic Chemistry (Deadline: 29 February 2024)
- Veterinary Drugs—2nd Edition (Deadline: 29 February 2024)
- Computational and Synthetic Approaches of Drug Discovery in Cancer and Neurological Disorders (Deadline: 29 February 2024)
- Medicinal Chemistry Advances in Neurodegenerative Disease Therapy (Deadline: 29 February 2024)
- Chemistry and Health: Nitrogen Heterocycle Chemistry and Medicinal Chemistry (Deadline: 29 February 2024)
- Bioactive Molecules: Isolation, Synthesis, Analysis, and Application (Deadline: 29 February 2024)
- Recent Advances in Protein-Drug Conjugates: From Bioanalytical, Drug Metabolism to Pharmacokinetics (Deadline: 15 March 2024)
- Molecular Modelling in Drug Design for the Identification of New Protein Targets and Their Signalling Pathways (Deadline: 15 March 2024)
- Biomimetic Nanotechnologies for Disease Diagnosis and Treatment (Deadline: 31 March 2024)
- Targeted Functional Probe: Current Research Trends and Applications (Deadline: 31 March 2024)
- Bioinformatic and Biochemical Identification of Phytochemical Drug Candidates (Deadline: 31 March 2024)
- Medicinal Chemistry in Europe IV (Deadline: 31 March 2024)
- Hallmarks and Biological Targets to Investigate Natural and Synthetic Compounds as Anticancer Drugs (Deadline: 31 March 2024)
- Biological Activity and Mechanism of Virus Inhibitors (Deadline: 31 March 2024)
- Application of Natural or Synthetic Products in Computer-Aided Drugs (Deadline: 31 March 2024)
- Coordination Complexes of 3D Metals as Anticancer, Anviral, Anmicrobial, Anfungal and An-Inflammatory Agents (Deadline: 30 April 2024)
- Emerging Horizons in Drug Discovery: Unveiling the Synergy of Ligand-Based and Structure-Based Methods (Deadline: 30 April 2024)
- Novel Kinase Inhibitors for the Treatment of Autoimmune and Inflammatory Diseases (Deadline: 30 April 2024)
- Current Advances in Pharmaceutical Analysis (Deadline: 30 April 2024)
- Novel Antitumor Drug: Discovery and Synthesis, 2nd Edition (Deadline: 30 April 2024)
- Peptidomimetics: Synthetic Tools for Drug Discovery and Development (Deadline: 30 April 2024)
- Targeting Cell Signaling Pathways in Anticancer Drug Design and Development (Deadline: 30 April 2024)
- Drug Discovery and Development: New Options for Old Diseases II (Deadline: 30 April 2024)
- Nanoparticle-Based Drug Delivery Systems (Deadline: 30 April 2024)
- Drug Design and Development for Dementia, Epilepsy, and Other Neurological Disorders Diseases (Deadline: 30 April 2024)
- Molecular Targets and Drug Discovery for Metabolic Disorders: Challenges, Recent Developments, and Prospects (Deadline: 31 May 2024)
- Heterocyclic Compounds: Synthesis and Medicinal Chemistry Applications (Deadline: 31 May 2024)
- Coordination Chemistry in Cancer Therapy (Deadline: 31 May 2024)
- Peptides and Small Molecules as Anti-Cancer Agents II (Deadline: 30 June 2024)
- Novel Agents in Photodynamic Therapy (Deadline: 31 August 2024)
- Small-Molecule Inhibitors: Synthesis, Cytotoxicity and Biological Activities (Deadline: 31 December 2024)
- Design, Synthesis, and Analysis of Potential Drugs, 3rd Edition (Deadline: 31 December 2024)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Antibiotics & Superbugs: New Strategies to Combat Antimicrobial Resistance
- Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes
- Efficient Pharmaceutical and Chemical Approaches for Anticancer Therapy: Design, Preliminary Evaluations, and Further Developments
- Herbal Medicine Research
- Molecular Docking
- Molecular Medicine
- Nanomedicine
- Novel Approache of Anticancer Therapy
- Poorly Soluble Drugs